Trial intelligence / Profile preview

Personalized Vitamin D Supplementation for Fatigue and Quality of Life in Colorectal Tumor Patients

DRKS00019907Phase 3Terminated

Sponsor
German Cancer Research Center
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in asthenia, colorectal cancer (CRC) and Vitamin D deficiency (VDD) comparing Dekristol personalized loading + maintenance with Placebo (2 arms). Primary endpoints: Tumor-associated fatigue and Quality of life. Started Apr 2020; status: terminated.

02

Drugs

cholecalciferol
03

Conditions

astheniacolorectal cancer (CRC)Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on DRKS00019907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00019907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call